DL-3-n-butylphthalide delays the onset and progression of diabetic cataract by inhibiting oxidative stress in rat diabetic model

DL-3-n-butylphthalide (NBP) is a therapeutic drug used for ischemic stroke treatment. Here, we investigated the impact of NBP on the development of rat diabetic cataract induced by intraperitoneal injection of streptozotocin (STZ). NBP was then administrated by oral gavage for nine weeks. Cataract d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fuxu, Ma, Jia, Han, Fei, Guo, Xiujin, Meng, Li, Sun, Yufeng, Jin, Cheng, Duan, Huijun, Li, Hang, Peng, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725374/
https://www.ncbi.nlm.nih.gov/pubmed/26759189
http://dx.doi.org/10.1038/srep19396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725374/
https://www.ncbi.nlm.nih.gov/pubmed/26759189
http://dx.doi.org/10.1038/srep19396

Ejemplares similares